Immupharma - Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Registrars: Computershare Investor Services PLC

Key Personnel

CEO: Timothy Paul McCarthy
Non-Executive Director: Lisa Baderoon, Sébastien Goudreau
Senior Independent Non-Executive Director: Laurence Reilly
Chief Operating Officer: Tim Franklin

Contact Details

Address: One Bartholomew Close, London, United Kingdom
Phone: +44 20 7152 4080
Fax: +44 20 7152 4001
Website: http://www.immupharma.co.uk/
Email:

Listings

ISIN: GB0033711010
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share